By using advanced techniques like lentiviral vectors, researchers have not only solved a complex medical problem but also opened a new era in healthcare.... Dec 12
Unlike current treatments that include drugs, blood transfusions, and bone marrow transplants, exa-cel aims to provide a one-time, DNA-altering solution. By modifying ... Nov 03
The biotech sector in the country has been seeing a lot of activity, and the government is also promoting startups in the industry. Immuneel Therapeutics ... Jun 23
Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics. ... Dec 24
Latest FDA drug approval update... Jun 24
AP103 is based on Amryt's gene-therapy platform technology and offers a potential treatment for patients with DEB... Dec 24
Today’s clinical supply chain and logistics market in Europe is expected to double by 2025 and more than triple by 2030... Dec 21
The acquisition will establish a new modality for drug discovery and development at Lilly ... Dec 15
We continue to be encouraged by the findings from this Phase 1/2 study, which now include durable factor VIII expression through one year of ... Dec 07
Shape Therapeutics, announces today the unveiling of the AAVidTM capsid discovery platform and results from its first AAV5 variant library in a non-human primate ... Dec 04
AskBio and Selecta expect to initiate a Phase 1 clinical trial of MMA-101 and ImmTOR for patients with MMA in the first half of ... Nov 21
The company believes that OTL-200 offers tremendous potential to transform the lives of many young patients with MLD... Nov 21
... Oct 27
Pfizer Inc. today announced that its investigational gene therapy candidate being developed to treat Duchenne muscular dystrophy ... Oct 01
City of Hope enters licensing agreement with Chimeric Therapeutics Limited to develop its pioneering chlorotoxin CAR T Cell therapy ... Sep 22
Previously acquired AveXis renamed as Novartis Gene Therapies... Sep 04
Catalent and Astrazeneca partners for the Covid vaccine manufacturing... Aug 26
New, €100 million facility will more than double existing production capacity. Supports large-scale commercial manufacturing of viral and gene therapy products... Apr 22
This is the world's first IRB-approved clinical trial aimed at reversing aging by at least 20 years; it is also the world's ... Dec 30
-Advertisements-
.jpeg)
Monday, October 05, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpeg)
.jpeg)
.png)